Dietary phenolics or polyphenols are mostly metabolized by the human gut microbiota. These metabolites appear to confer the beneficial health effects attributed to phenolics. Microbial composition affects the type of metabolites produced. Reciprocally, phenolics modulate microbial composition. Understanding this relationship could be used to positively impact health by phenolic supplementation and thus create favorable colonic conditions. This study explored the effect of six stilbenoids (batatasin III, oxyresveratrol, piceatannol, pinostilbene, resveratrol, thunalbene) on the gut microbiota composition. Stilbenoids were anaerobically fermented with fecal bacteria from four donors, samples were collected at 0 and 24 h, and effects on the microbiota were assessed by 16S rRNA gene sequencing. Statistical tests identified affected microbes at three taxonomic levels. Observed microbial composition modulation by stilbenoids included a decrease in the Firmicutes to Bacteroidetes ratio, a decrease in the relative abundance of strains from the genus Clostridium, and effects on the family Lachnospiraceae. A frequently observed effect was a further decrease of the relative abundance when compared to the control. An opposite effect to the control was observed for Faecalibacterium prausnitzii, whose relative abundance increased. Observed effects were more frequently attributed to resveratrol and piceatannol, followed by thunalbene and batatasin III.

Department of Food Quality and Safety Czech University of Life Sciences Prague Kamycka 129 16500 Prague 6 Suchdol Czech Republic

Department of Microbiology Nutrition and Dietetics Czech University of Life Sciences Prague Kamycka 129 16500 Prague 6 Suchdol Czech Republic

Department of Natural Drugs Faculty of Pharmacy University of Veterinary and Pharmaceutical Sciences Brno Palackeho 1946 1 61242 Brno Czech Republic

Institute of Animal Physiology and Genetics CAS v v i Videnska 1083 14220 Prague Czech Republic

Zobrazit více v PubMed

Edwards C.A., Havlik J., Cong W., Mullen W., Preston T., Morrison D.J., Combet E. Polyphenols and health: Interactions between fibre, plant polyphenols and the gut microbiota. Nutr. Bull. 2017;42:356–360. doi: 10.1111/nbu.12296. PubMed DOI PMC

Ozdal T., Sela D.A., Xiao J., Boyacioglu D., Chen F., Capanoglu E. The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients. 2016;8:78. doi: 10.3390/nu8020078. PubMed DOI PMC

Pérez-Jiménez J., Fezeu L., Touvier M., Arnault N., Manach C., Hercberg S., Galan P., Scalbert A. Dietary intake of 337 polyphenols in French adults. Am. J. Clin. Nutr. 2011;93:1220–1228. doi: 10.3945/ajcn.110.007096. PubMed DOI

Akinwumi B.C., Bordun K.A.M., Anderson H.D. Biological activities of stilbenoids. Int. J. Mol. Sci. 2018;19:792. doi: 10.3390/ijms19030792. PubMed DOI PMC

The WHO Monica Project . World Health Statistics Annual. WHO; Geneva, Switzerland: 1989. A Worlwide Monitoring System for Cardiovascular Diseases: Cardiovascular Mortality & Risk Factors in Selected Communities; pp. 27–149.

Tomás-Barberán F.A., Selma M.V., Espín J.C. Interactions of gut microbiota with dietary polyphenols and consequences to human health. Curr. Opin. Clin. Nutr. Metab. Care. 2016;19:471–476. doi: 10.1097/MCO.0000000000000314. PubMed DOI

Carrera-Quintanar L., López Roa R.I., Quintero-Fabián S., Sánchez-Sánchez M.A., Vizmanos B., Ortuño-Sahagún D. Phytochemicals That Influence Gut Microbiota as Prophylactics and for the Treatment of Obesity and Inflammatory Diseases. Mediators Inflamm. 2018 doi: 10.1155/2018/9734845. PubMed DOI PMC

Bode L.M.L.M., Bunzel D., Huch M., Cho G.G.S., Ruhland D., Bunzel M., Bub A., Franz C.M.C.M.A.P., Kulling S.E.S.E. In vivo and in vitro metabolism of trans -resveratrol by human gut. Am. J. Clin. Nutr. 2013;97:295–309. doi: 10.3945/ajcn.112.049379. PubMed DOI

Cueva C., Sánchez-Patán F., Monagas M., Walton G.E., Gibson G.R., Martín-Álvarez P.J., Bartolomé B., Moreno-Arribas M.V. In vitro fermentation of grape seed flavan-3-ol fractions by human faecal microbiota: Changes in microbial groups and phenolic metabolites. FEMS Microbiol. Ecol. 2013;83:792–805. doi: 10.1111/1574-6941.12037. PubMed DOI

Monagas M., Urpi-Sarda M., Sánchez-Patán F., Llorach R., Garrido I., Gómez-Cordovés C., Andres-Lacueva C., Bartolomé B. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct. 2010;1:233–253. doi: 10.1039/c0fo00132e. PubMed DOI

Guo W., Polich E.D., Su J., Gao Y., Christopher D.M., Allan A.M., Wang F., Wang G., Zhao X. The Role of the Gut Microbiota in the Metabolism of Polyphenols as Characterized by Gnotobiotic Mice. Cell Rep. 2015;11:1651–1666. doi: 10.1016/j.celrep.2015.05.013. PubMed DOI PMC

Etxeberria U., Fernández-Quintela A., Milagro F.I., Aguirre L., Martínez J.A., Portillo M.P. Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J. Agric. Food Chem. 2013;61:9517–9533. doi: 10.1021/jf402506c. PubMed DOI

van Duynhoven J., Vaughan E.E., Jacobs D.M., Kemperman R.A., van Velzen E.J.J., Gross G., Roger L.C., Possemiers S., Smilde A.K., Dore J., et al. Metabolic fate of polyphenols in the human superorganism. Proc. Natl. Acad. Sci. USA. 2011;108:4531–4538. doi: 10.1073/pnas.1000098107. PubMed DOI PMC

Espín J.C., González-Sarrías A., Tomás-Barberán F.A. The gut microbiota: A key factor in the therapeutic effects of (poly)phenols. Biochem. Pharmacol. 2017;139:82–93. doi: 10.1016/j.bcp.2017.04.033. PubMed DOI

Cueva C., Gil-Sánchez I., Ayuda-Durán B., González-Manzano S., González-Paramás A.M., Santos-Buelga C., Bartolomé B., Victoria Moreno-Arribas M. An integrated view of the effects of wine polyphenols and their relevant metabolites on gut and host health. Molecules. 2017;22 doi: 10.3390/molecules22010099. PubMed DOI PMC

Dueñas M., Muñoz-González I., Cueva C., Jiménez-Girón A., Sánchez-Patán F., Santos-Buelga C., Moreno-Arribas M.V., Bartolomé B. A survey of modulation of gut microbiota by dietary polyphenols. Biomed. Res. Int. 2015;8050902 doi: 10.1155/2015/850902. PubMed DOI PMC

Larrosa M., Yañéz-Gascón M.J., Selma M.V., González-Sarrías A., Toti S., Cerón J.J., Tomás-Barberán F., Dolara P., Espín J.C. Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. J. Agric. Food Chem. 2009;57:2211–2220. doi: 10.1021/jf803638d. PubMed DOI

Ding S., Jiang H., Fang J. Regulation of Immune Function by Polyphenols. J. Immunol. Res. 2018;2018:1–8. doi: 10.1155/2018/1264074. PubMed DOI PMC

Braune A., Blaut M. Bacterial species involved in the conversion of dietary flavonoids in the human gut. Gut Microbes. 2016;7:216–234. doi: 10.1080/19490976.2016.1158395. PubMed DOI PMC

Tomas-Barberan F.A., Selma M.V., Espín J.C. Polyphenols’ Gut Microbiota Metabolites: Bioactives or Biomarkers? J. Agric. Food Chem. 2018;66:3593–3594. doi: 10.1021/acs.jafc.8b00827. PubMed DOI

Marín L., Miguélez E.M., Villar C.J., Lombó F. Bioavailability of dietary polyphenols and gut microbiota metabolism: Antimicrobial properties. Biomed Res. Int. 2015 doi: 10.1155/2015/905215. PubMed DOI PMC

Kemperman R.A., Gross G., Mondot S., Possemiers S., Marzorati M., Van de Wiele T., Doré J., Vaughan E.E. Impact of polyphenols from black tea and red wine/grape juice on a gut model microbiome. Food Res. Int. 2013;53:659–669. doi: 10.1016/j.foodres.2013.01.034. DOI

Volstatova T., Marsik P., Rada V., Geigerova M., Havlik J. Effect of apple extracts and selective polyphenols on the adhesion of potential probiotic strains of Lactobacillus gasseri R and Lactobacillus casei FMP. J. Funct. Foods. 2017;35:391–397. doi: 10.1016/j.jff.2017.06.005. DOI

Havlik J., Edwards C.A. Non-extractable Polyphenols and Carotenoids. RSC Publishing; Cambridge, UK: 2018. Non-extractable Polyphenols into Polyphenol Research; pp. 241–262.

Tzounis X., Vulevic J., Kuhnle G.G.C., George T., Leonczak J., Gibson G.R., Kwik-Uribe C., Spencer J.P.E. Flavanol monomer-induced changes to the human faecal microflora. Br. J. Nutr. 2008;99:782–792. doi: 10.1017/S0007114507853384. PubMed DOI

Mayta-Apaza A.C., Pottgen E., De Bodt J., Papp N., Marasini D., Howard L., Abranko L., Van de Wiele T., Lee S.O., Carbonero F. Impact of tart cherries polyphenols on the human gut microbiota and phenolic metabolites in vitro and in vivo. J. Nutr. Biochem. 2018;59:160–172. doi: 10.1016/j.jnutbio.2018.04.001. PubMed DOI

Catinean A., Neag M.A., Muntean D.M., Bocsan I.C., Buzoianu A.D. An overview on the interplay between nutraceuticals and gut microbiota. PeerJ. 2018;6:e4465. doi: 10.7717/peerj.4465. PubMed DOI PMC

Bialonska D., Kasimsetty S.G., Schrader K.K., Ferreira D. The effect of pomegranate (punica granatum l.) byproducts and ellagitannins on the growth of human gut bacteria. J. Agric. Food Chem. 2009;57:8344–8349. doi: 10.1021/jf901931b. PubMed DOI

Giuliani C., Marzorati M., Innocenti M., Vilchez-Vargas R., Vital M., Pieper D.H., Van De Wiele T., Mulinacci N. Dietary supplement based on stilbenes: A focus on gut microbial metabolism by the: In vitro simulator M-SHIME®. Food Funct. 2016;7:4564–4575. doi: 10.1039/C6FO00784H. PubMed DOI

Rowland I., Gibson G., Heinken A., Scott K., Swann J., Thiele I., Tuohy K. Gut microbiota functions: Metabolism of nutrients and other food components. Eur. J. Nutr. 2018;57:1–24. doi: 10.1007/s00394-017-1445-8. PubMed DOI PMC

Scarano A., Butelli E., De Santis S., Cavalcanti E., Hill L., De Angelis M., Giovinazzo G., Chieppa M., Martin C., Santino A. Combined Dietary Anthocyanins, Flavonols, and Stilbenoids Alleviate Inflammatory Bowel Disease Symptoms in Mice. Front. Nutr. 2018;4:1–10. doi: 10.3389/fnut.2017.00075. PubMed DOI PMC

Hervert-Hernández D., Goñi I. Dietary polyphenols and human gut microbiota: A review. Food Rev. Int. 2011;27:154–169. doi: 10.1080/87559129.2010.535233. DOI

Etxeberria U., Hijona E., Aguirre L., Milagro F.I., Bujanda L., Rimando A.M., Martínez J.A., Portillo M.P. Pterostilbene-induced changes in gut microbiota composition in relation to obesity. Mol. Nutr. Food Res. 2017;61:1500906. doi: 10.1002/mnfr.201500906. PubMed DOI

David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., Ling A.V., Devlin A.S., Varma Y., Fischbach M.A., et al. Diet Rapidly and Reproducibly Alters the Human Gut Microbiome. Nature. 2014;505:559–563. doi: 10.1038/nature12820. PubMed DOI PMC

Healey G.R., Murphy R., Brough L., Butts C.A., Coad J. Interindividual variability in gut microbiota and host response to dietary interventions. Nutr. Rev. 2017;75:1059–1080. doi: 10.1093/nutrit/nux062. PubMed DOI

Koliada A., Syzenko G., Moseiko V., Budovska L., Puchkov K., Perederiy V., Gavalko Y., Dorofeyev A., Romanenko M., Tkach S., et al. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017;17:4–9. doi: 10.1186/s12866-017-1027-1. PubMed DOI PMC

Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027. doi: 10.1038/nature05414. PubMed DOI

Qiao Y., Sun J., Xia S., Tang X., Shi Y., Le G. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food Funct. 2014;5:1241–1249. doi: 10.1039/c3fo60630a. PubMed DOI

Morrison D.J., Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189–200. doi: 10.1080/19490976.2015.1134082. PubMed DOI PMC

Biagi E., Franceschi C., Rampelli S., Severgnini M., Ostan R., Turroni S., Consolandi C., Quercia S., Scurti M., Monti D., et al. Gut Microbiota and Extreme Longevity. Curr. Biol. 2016;26:1480–1485. doi: 10.1016/j.cub.2016.04.016. PubMed DOI

Benson D.A., Karsch-Mizrachi I., Lipman D.J., Ostell J., Wheeler D.L. GenBank. Nucleic Acids Res. 2003;31:23–27. doi: 10.1093/nar/gkg057. PubMed DOI PMC

Sayers E.W., Barrett T., Benson D.A., Bolton E., Bryant S.H., Canese K., Chetvernin V., Church D.M., DiCuccio M., Federhen S., et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2012;40:5–15. doi: 10.1093/nar/gkr1184. PubMed DOI PMC

Kong F., Hua Y., Zeng B., Ning R., Li Y., Zhao J. Gut microbiota signatures of longevity. Curr. Biol. 2016;26:R832–R833. doi: 10.1016/j.cub.2016.08.015. PubMed DOI

O’Mahony L. Host-microbiome interactions in health and disease. Clin. Liver Dis. 2015;5:142–144. doi: 10.1002/cld.484. PubMed DOI PMC

Ramakrishna B.S. Role of the gut microbiota in human nutrition and metabolism. J. Gastroenterol. Hepatol. 2013;28:9–17. doi: 10.1111/jgh.12294. PubMed DOI

Uchiyama S., Ueno T., Suzuki T. Identification of a newly isolated equol-producing lactic acid bacterium from the human feces. J. Intest. Microbiol. 2007;21:217–220.

Gaya P., Medina M., Sánchez-Jiménez A., Landete J. Phytoestrogen Metabolism by Adult Human Gut Microbiota. Molecules. 2016;21:1034. doi: 10.3390/molecules21081034. PubMed DOI PMC

Summaries S. Dysbiosis of the Faecal Microbiota in Patients with Crohn’s Disease and Their Unaffected Relatives. Gut. 2011;9:166–168. PubMed

Jeffery I.B., Claesson M.J., O′toole P.W. Categorization of the gut microbiota: Enterotypes or gradients? Grouping the microbiota of individual subjects into compositional categories, or enterotypes, based on the dominance of certain genera may have oversimplified a complex situation. Nat. Rev. Microbiol. 2012;10:591–592. doi: 10.1038/nrmicro2859. PubMed DOI

Lawson P.A., Finegold S.M. Reclassification of Ruminococcus obeum as Blautia obeum comb. nov. Int. J. Syst. Evol. Microbiol. 2015;65:789–793. doi: 10.1099/ijs.0.000015. PubMed DOI

Shortt C., Hasselwander O., Meynier A., Nauta A., Fernández E.N., Putz P., Rowland I., Swann J., Türk J., Vermeiren J., et al. Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients. Eur. J. Nutr. 2018;57:25–49. doi: 10.1007/s00394-017-1546-4. PubMed DOI PMC

Al Shukor N., Van Camp J., Gonzales G.B., Staljanssens D., Struijs K., Zotti M.J., Raes K., Smagghe G. Angiotensin-converting enzyme inhibitory effects by plant phenolic compounds: A study of structure activity relationships. J. Agric. Food Chem. 2013;61:11832–11839. doi: 10.1021/jf404641v. PubMed DOI

Karamać M., Amarowicz R. Inhibition of Pancreatic Lipase by Phenolic Acids-Examination in vitro. Zeitschrift fur Naturforsch. Sect. C J. Biosci. 1996;51:903–906. doi: 10.1515/znc-1996-11-1222. PubMed DOI

Sandra Goncalves A.R. Inhibitory Properties of Phenolic Compounds Against Enzymes Linked with Human Diseases. In: Soto-Hernandez M., Tenango M.P., García-Mateos R., editors. Phenolic Compounds-Biological Activity. Volume 2. InTech; London, UK: 2017. pp. 581–770.

McMurry J. Fundamentals of Organic Chemistry, 4th Ed. Brooks/Cole Publishing Company; Pacific Grove, CA, USA: 1998.

Iuga C., Alvarez-Idaboy J.R., Russo N. Antioxidant Activity of trans -Resveratrol toward Hydroxyl and Hydroperoxyl Radicals: A Quantum Chemical and Computational Kinetics Study. J. Org. Chem. 2012;77:3868–3877. doi: 10.1021/jo3002134. PubMed DOI

Buchholz T., Melzig M.F. Polyphenolic Compounds as Pancreatic Lipase Inhibitors. Planta Med. 2015;81:771–783. doi: 10.1055/s-0035-1546173. PubMed DOI

Xiao J., Ni X., Kai G., Chen X. A review on structure-activity relationship of dietary polyphenols inhibiting α-amylase. Crit. Rev. Food Sci. Nutr. 2013;53:497–506. doi: 10.1080/10408398.2010.548108. PubMed DOI

Tadera K., Minami Y., Takamatsu K., Matsuoka T. Inhibition of α-Glucosidase and α-Amylase by Flavonoids. J. Nutr. Sci. Vitaminol. (Tokyo) 2006;52:149–153. doi: 10.3177/jnsv.52.149. PubMed DOI

Lo Piparo E., Scheib H., Frei N., Williamson G., Grigorov M., Chou C.J. Flavonoids for controlling starch digestion: Structural requirements for inhibiting human α-amylase. J. Med. Chem. 2008;51:3555–3561. doi: 10.1021/jm800115x. PubMed DOI

Burapan S., Kim M., Han J. Curcuminoid Demethylation as an Alternative Metabolism by Human Intestinal Microbiota. J. Agric. Food Chem. 2017;65:3305–3310. doi: 10.1021/acs.jafc.7b00943. PubMed DOI

Blaut M., Schoefer L., Braune A. Transformation of Flavonoids by Intestinal Microorganisms. Int. J. Vitam. Nutr. Res. 2003;73:79–87. doi: 10.1024/0300-9831.73.2.79. PubMed DOI

Jin J.S., Zhao Y.F., Nakamura N., Akao T., Kakiuchi N., Min B.S., Hattori M. Enantioselective Dehydroxylation of Enterodiol and Enterolactone Precursors by Human Intestinal Bacteria. Biol. Pharm. Bull. 2007;30:2113–2119. doi: 10.1248/bpb.30.2113. PubMed DOI

Wang L.-Q., Meselhy M.R., Li Y., Qin G.-W., HAattori M. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone. Chem. Pharm. Bull. 2000;48:1606–1610. doi: 10.1248/cpb.48.1606. PubMed DOI

Etxeberria U., Arias N., Boqué N., Macarulla M.T., Portillo M.P., Martínez J.A., Milagro F.I. Reshaping faecal gut microbiota composition by the intake of trans -resveratrol and quercetin in high-fat sucrose diet-fed rats. J. Nutr. Biochem. 2015;26:651–660. doi: 10.1016/j.jnutbio.2015.01.002. PubMed DOI

González-Barrio R., Edwards C.A., Crozier A. Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: In vivo and in vitro studies. Drug Metab. Dispos. 2011;39:1680–1688. doi: 10.1124/dmd.111.039651. PubMed DOI

Jaganath I.B., Mullen W., Lean M.E.J., Edwards C.A., Crozier A. In vitro catabolism of rutin by human fecal bacteria and the antioxidant capacity of its catabolites Indu. Free Radic. Biol. Med. 2009;47:1180–1189. doi: 10.1016/j.freeradbiomed.2009.07.031. PubMed DOI

Edwards C.A., Gibson G., Champ M., Jensen B.-B., Mathers J.C., Nagengast F., Rumney C., Quehl A. In Vitro Method for Quantification of the Fermentation of Starch by Human Faecal Bacteria. J. Sci. Food Agric. 1996;71:209–217. doi: 10.1002/(SICI)1097-0010(199606)71:2<209::AID-JSFA571>3.0.CO;2-4. DOI

Juretschko S., Timmermann G., Schmid M., Schleifer K., Pommerening-ro A. Combined Molecular and Conventional Analyses of Nitrifying Bacterium Diversity in Activated Sludge: Nitrosococcus mobilis and Nitrospira-Like Bacteria as Dominant Populations. Appl. Environ. Microbiol. 1998;64:3042–3051. PubMed PMC

Fliegerova K., Tapio I., Bonin A., Mrazek J., Callegari M.L., Bani P., Bayat A., Vilkki J., Kopečný J., Shingfield K.J., et al. Effect of DNA extraction and sample preservation method on rumen bacterial population. Anaerobe. 2014;29:80–84. doi: 10.1016/j.anaerobe.2013.09.015. PubMed DOI

Milani C., Hevia A., Foroni E., Duranti S., Turroni F., Lugli G.A., Sanchez B., Martín R., Gueimonde M., van Sinderen D., et al. Assessing the Fecal Microbiota: An Optimized Ion Torrent 16S rRNA Gene-Based Analysis Protocol. PLoS ONE. 2013;8:e68739. doi: 10.1371/journal.pone.0068739. PubMed DOI PMC

Caporaso J.G., Kuczynski J., Stombaugh J., Bittinger K., Bushman F.D., Costello E.K., Fierer N., Peña A.G., Goodrich J.K., Gordon J.I., et al. correspondence QIIME allows analysis of high- throughput community sequencing data Intensity normalization improves color calling in SOLiD sequencing. Nature. 2010;7:335–336. PubMed PMC

Edgar R.C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460–2461. doi: 10.1093/bioinformatics/btq461. PubMed DOI

DeSantis T.Z., Hugenholtz P., Larsen N., Rojas M., Brodie E.L., Keller K., Huber T., Dalevi D., Hu P., Andersen G.L. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 2006;72:5069–5072. doi: 10.1128/AEM.03006-05. PubMed DOI PMC

Mutual Interactions of Silymarin and Colon Microbiota in Healthy Young and Healthy Elder Subjects

Enhancing Bioavailability of Nutraceutically Used Resveratrol and Other Stilbenoids

Metabolism of Stilbenoids by Human Faecal Microbiota